We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

ELISA – Products

Save Time and Sample – Automate ELISAs With Ella™ content piece image
Product
Advertisement

Save Time and Sample – Automate ELISAs With Ella™

Eliminate the challenges that come with manual ELISAs. Meet Ella™ — your next generation automated ELISA instrument from Bio-Techne. In just 90 minutes you get highly reproducible validated assay data with no manual steps.
Monitoring Protein Titer and Glycosylation Simultaneously content piece image
Product
Advertisement

Monitoring Protein Titer and Glycosylation Simultaneously

Drug product glycosylation is a critical quality attribute (CQA) due to its potential impact on pharmacokinetics properties and stability of the product. The ability to view and choose from desired titer and glycosylation profiles at the same time provides more in-depth knowledge that facilitates more informed decisions.
Selectins: Cell Adhesion Molecules Regulate the Immune System and Tumor Microenvironment content piece image
Product
Advertisement

Selectins: Cell Adhesion Molecules Regulate the Immune System and Tumor Microenvironment

Selectins are actively involved in constitutive lymphocyte homing, chronic and acute inflammation, and cancer metastasis. Therefore, they are current hot targets for developing therapeutics to treat various diseases, such as sickle cell disease and malignancies.
Where Do We Go From Here: A Reflection of COVID-19 content piece image
App Note / Case Study

Where Do We Go From Here: A Reflection of COVID-19

Download this app note to explore various solutions designed to improve COVID-19 detection and the development of vaccines and therapeutics.
Challenging Host Cell Protein Assays for Improved Risk Mitigation content piece image
Whitepaper

Challenging Host Cell Protein Assays for Improved Risk Mitigation

At high levels, host cell proteins (HCPs) can cause immunogenic responses and reduced efficacy of biologics, so it is imperative to have an effective, robust HCP assay to detect them and mitigate these effects.
CSFs: Burgeoning Potential in Inflammatory Disorders and Cancer content piece image
Product
Advertisement

CSFs: Burgeoning Potential in Inflammatory Disorders and Cancer

Sino Biological Announces Successful Closing of 4.98 Billion RMB Public Offering  content piece image
Product News

Sino Biological Announces Successful Closing of 4.98 Billion RMB Public Offering

Sino Biological, Inc. has announced a successful listing on the Shenzhen Stock Exchange subsidiary ChiNext under the stock abbreviation Sino Biological and stock code 301047. A total of 17 million shares were issued for a total of 4.98 billion RMB raised during this initial public offering.
Antibodies for Influenza Antigen Test content piece image
Product
Advertisement

Antibodies for Influenza Antigen Test

Profiling Host Responses in COVID-19 Infections content piece image
Whitepaper

Profiling Host Responses in COVID-19 Infections

Download this whitepaper to discover how next-generation ELISA technology can accelerate biomarker discovery and provide in-depth analysis of COVID-19 host cytokine levels.
Automate Your SARS-CoV-2 S1/RBD IgG Ab ELISA content piece image
App Note / Case Study

Automate Your SARS-CoV-2 S1/RBD IgG Ab ELISA

Download this app note to discover an automated SARS-CoV-2 IgG Ab ELISA workflow that delivers stable assay performance across the entire plate and produces more than 1,000 results in 11 hours.
Advertisement